Case series of using automated insulin delivery to improve glycaemic control in people with type 1 diabetes and end stage kidney disease on haemodialysis

Khuram Chaudhry; Rebecca Hyslop; Thomas Johnston; Siobhan Pender; Sufyan Hussain; Janaka Karalliedde

doi:10.1016/j.diabres.2024.111800

Case series of using automated insulin delivery to improve glycaemic control in people with type 1 diabetes and end stage kidney disease on haemodialysis

Diabetes Res Clin Pract. 2024 Nov:217:111800. doi: 10.1016/j.diabres.2024.111800. Epub 2024 Aug 14.

Authors

Khuram Chaudhry¹, Rebecca Hyslop¹, Thomas Johnston¹, Siobhan Pender¹, Sufyan Hussain², Janaka Karalliedde³

Affiliations

¹ Department of Diabetes and Endocrinology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
² Department of Diabetes and Endocrinology, Guy's and St Thomas' NHS Foundation Trust, London, UK; School of Cardiovascular, Metabolic Medicine and Sciences, King's College London, London, UK.
³ Department of Diabetes and Endocrinology, Guy's and St Thomas' NHS Foundation Trust, London, UK; School of Cardiovascular, Metabolic Medicine and Sciences, King's College London, London, UK. Electronic address: [email protected].

PMID: 39151730
DOI: 10.1016/j.diabres.2024.111800

Abstract

Automated insulin delivery (AID) in people with type 1 diabetes (pwT1D) and end-stage kidney disease (ESKD) on haemodialysis (HD) has not been reported previously. We describe practical considerations and our findings in four pwT1D on HD for ESKD where AID was safely implemented, with significant improvements in time in range.

Keywords: Automated insulin delivery; End-stage kidney disease; Haemodialysis; Type 1 diabetes.

Publication types

Case Reports

MeSH terms

Adult
Aged
Blood Glucose / analysis
Blood Glucose / drug effects
Diabetes Mellitus, Type 1* / blood
Diabetes Mellitus, Type 1* / complications
Diabetes Mellitus, Type 1* / drug therapy
Diabetic Nephropathies / therapy
Female
Glycemic Control* / methods
Humans
Hypoglycemic Agents / administration & dosage
Hypoglycemic Agents / therapeutic use
Insulin Infusion Systems*
Insulin* / administration & dosage
Insulin* / therapeutic use
Kidney Failure, Chronic* / complications
Kidney Failure, Chronic* / therapy
Male
Middle Aged
Renal Dialysis* / methods

Substances

Insulin
Hypoglycemic Agents
Blood Glucose